SCHEMBL14867940

SCHEMBL14867940

c1ccc(-c2cccc(-c3ccc4sc5ccc(-n6c7ccc(-n8c9ccccc9c9ccccc98)cc7c7cc(-n8c9ccccc9c9ccccc98)ccc76)cc5c4c3)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TSPO P30536 4/20 0.38
LIMK1 P53667 1/20 0.36
HDAC4 P56524 1/20 0.36
PIM3 Q86V86 1/20 0.35
RAC2 P15153 1/20 0.34
RAC3 P60763 1/20 0.34
CDC42 P60953 1/20 0.34
RAC1 P63000 1/20 0.34
EDNRB P24530 1/20 0.34
EDNRA P25101 1/20 0.34
DNM1 Q05193 1/20 0.33
ROCK1 Q13464 1/20 0.32
NPY5R Q15761 1/20 0.32
NR3C1 P04150 1/20 0.32
KMT2A Q03164 1/20 0.31
F9 P00740 1/20 0.31
GPR3 P46089 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17228735 1.00 KDM4E (0.41) KDM4EATML3MBTL1TSPOLIMK1
SCHEMBL17166681 1.00 KDM4E (0.41) KDM4EATML3MBTL1TSPOLIMK1
SCHEMBL17166715 1.00 KDM4E (0.41) KDM4EATML3MBTL1TSPOLIMK1
SCHEMBL17166790 1.00 KDM4E (0.41) KDM4EATML3MBTL1TSPOLIMK1
SCHEMBL17166796 0.97 KDM4E (0.39) KDM4EATML3MBTL1TSPOLIMK1
SCHEMBL17166753 0.97 KDM4E (0.39) KDM4EATML3MBTL1TSPOLIMK1
SCHEMBL17166788 0.97 KDM4E (0.39) KDM4EATML3MBTL1TSPOLIMK1
SCHEMBL17248412 0.97 KDM4E (0.39) KDM4EATML3MBTL1TSPOLIMK1
SCHEMBL14867999 0.97 KDM4E (0.43) KDM4EATML3MBTL1TSPOLIMK1
SCHEMBL17166663 0.97 L3MBTL1 (0.43) KDM4EATML3MBTL1TSPOLIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895966-B2 Material for organic electroluminescence element, and organic electroluminescence element using same IDEMITSU KOSAN CO., LTD. (JP) 2014-11-25 US disclosed
US-8895966-B2 Material for organic electroluminescence element, and organic electroluminescence element using same IDEMITSU KOSAN CO., LTD. (JP) 2014-11-25 US disclosed
US-20130092905-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-04-18 US disclosed
US-20130092905-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130092905-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME LEF1, ORMDL3, CD99 KDM4E 1369/4885ATM 2422/4885L3MBTL1 1519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.